Chiloscyllium plagiosum isolate BGI_BamShark_2017 chromosome 38, ASM401019v2, whole genome shotgun sequence.
Chiloscyllium plagiosum (whitespotted bambooshark)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Hemiscylliidae; Chiloscyllium.
REFSEQ INFORMATION: The reference sequence is identical to\nCM012993.1.\nAssembly name: ASM401019v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the BGI on 2019/01/10. The\noriginal whole-genome shotgun project has the accession\nQPFF00000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: BGI\nAssembly Method :: platanus v. 1.2.4; 3ddna v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 280.0x\nSequencing Technology :: BGIseq-500\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Chiloscyllium plagiosum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
gastrula zinc finger protein XlCGF49.1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
gastrula zinc finger protein XlCGF49.1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
gastrula zinc finger protein XlCGF49.1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
gastrula zinc finger protein XlCGF49.1-like, transcript variant X2
gastrula zinc finger protein XlCGF49.1-like
gastrula zinc finger protein XlCGF17.1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
gastrula zinc finger protein XlCGF17.1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
gastrula zinc finger protein XlCGF17.1-like, transcript variant X5
gastrula zinc finger protein XlCGF17.1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
gastrula zinc finger protein XlCGF17.1-like, transcript variant X2
gastrula zinc finger protein XlCGF17.1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ribosome biogenesis protein BMS1 homolog
primary cilium assembly protein FAM149B1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
primary cilium assembly protein FAM149B1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
primary cilium assembly protein FAM149B1-like isoform X2
COORDINATES: polyA evidence [ECO:0006239]
tetraspanin-5-like, transcript variant X2
tetraspanin-5-like, transcript variant X1
tetraspanin-5-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
tetraspanin-5-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
DnaJ (Hsp40) homolog, subfamily C, member 9
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X4
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X1
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X3
nuclear factor NF-kappa-B p100 subunit-like, transcript variant X2
nuclear factor NF-kappa-B p100 subunit-like isoform X2
nuclear factor NF-kappa-B p100 subunit-like isoform X1
leucine-rich repeat-containing protein 20-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
leucine-rich repeat-containing protein 20-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
leucine-rich repeat-containing protein 20-like
transforming growth factor beta regulator 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
polyunsaturated fatty acid 5-lipoxygenase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88% coverage of the annotated genomic feature by RNAseq alignments
DBF4-type zinc finger-containing protein 2 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 77% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
fatty acid-binding protein, intestinal-like, transcript variant X2
fatty acid-binding protein, intestinal-like isoform X2
fatty acid-binding protein, intestinal-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
fatty acid-binding protein, intestinal-like isoform X1
phosphoinositide-3-kinase adaptor protein 1, transcript variant X2
phosphoinositide-3-kinase adaptor protein 1, transcript variant X3
phosphoinositide-3-kinase adaptor protein 1, transcript variant X1
phosphoinositide 3-kinase adapter protein 1 isoform X2
phosphoinositide 3-kinase adapter protein 1 isoform X3
phosphoinositide 3-kinase adapter protein 1 isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X1
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X3
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X4
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X1
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X3
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X4
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X5
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X2
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X2
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform, transcript variant X6
serine/threonine-protein phosphatase 2B catalytic subunit beta isoform isoform X6
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01229
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85% coverage of the annotated genomic feature by RNAseq alignments
sorbin and SH3 domain-containing protein 1-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X23
sorbin and SH3 domain-containing protein 1-like, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X13
sorbin and SH3 domain-containing protein 1-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X20
sorbin and SH3 domain-containing protein 1-like, transcript variant X15
sorbin and SH3 domain-containing protein 1-like, transcript variant X21
sorbin and SH3 domain-containing protein 1-like, transcript variant X1
sorbin and SH3 domain-containing protein 1-like, transcript variant X2
sorbin and SH3 domain-containing protein 1-like, transcript variant X12
sorbin and SH3 domain-containing protein 1-like, transcript variant X3
sorbin and SH3 domain-containing protein 1-like, transcript variant X7
sorbin and SH3 domain-containing protein 1-like, transcript variant X8
sorbin and SH3 domain-containing protein 1-like, transcript variant X16
sorbin and SH3 domain-containing protein 1-like, transcript variant X4
sorbin and SH3 domain-containing protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X18
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X19
sorbin and SH3 domain-containing protein 1-like, transcript variant X24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X26
sorbin and SH3 domain-containing protein 1-like, transcript variant X27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like isoform X5
sorbin and SH3 domain-containing protein 1-like isoform X16
sorbin and SH3 domain-containing protein 1-like isoform X6
sorbin and SH3 domain-containing protein 1-like isoform X17
sorbin and SH3 domain-containing protein 1-like isoform X22
sorbin and SH3 domain-containing protein 1-like isoform X26
sorbin and SH3 domain-containing protein 1-like isoform X24
sorbin and SH3 domain-containing protein 1-like isoform X23
sorbin and SH3 domain-containing protein 1-like isoform X25
sorbin and SH3 domain-containing protein 1-like isoform X1
sorbin and SH3 domain-containing protein 1-like isoform X13
sorbin and SH3 domain-containing protein 1-like isoform X2
sorbin and SH3 domain-containing protein 1-like isoform X10
sorbin and SH3 domain-containing protein 1-like isoform X19
sorbin and SH3 domain-containing protein 1-like isoform X20
sorbin and SH3 domain-containing protein 1-like isoform X3
sorbin and SH3 domain-containing protein 1-like isoform X7
sorbin and SH3 domain-containing protein 1-like isoform X8
sorbin and SH3 domain-containing protein 1-like isoform X14
sorbin and SH3 domain-containing protein 1-like isoform X11
sorbin and SH3 domain-containing protein 1-like isoform X12
sorbin and SH3 domain-containing protein 1-like isoform X18
sorbin and SH3 domain-containing protein 1-like isoform X21
sorbin and SH3 domain-containing protein 1-like isoform X4
sorbin and SH3 domain-containing protein 1-like, transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
sorbin and SH3 domain-containing protein 1-like, transcript variant X9
sorbin and SH3 domain-containing protein 1-like isoform X9
sorbin and SH3 domain-containing protein 1-like isoform X15
sorbin and SH3 domain-containing protein 1-like
PDZ and LIM domain 1 (elfin), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
PDZ and LIM domain 1 (elfin), transcript variant X2
PDZ and LIM domain 1 (elfin), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00012
growth hormone inducible transmembrane protein, transcript variant X1
growth hormone inducible transmembrane protein, transcript variant X2
growth hormone inducible transmembrane protein, transcript variant X3
growth hormone-inducible transmembrane protein
S-adenosylmethionine synthase-like, transcript variant X2
S-adenosylmethionine synthase-like, transcript variant X1
S-adenosylmethionine synthase-like isoform X1
S-adenosylmethionine synthase-like isoform X2
uncharacterized protein LOC555816 homolog
uncharacterized protein si:ch1073-126c3.2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
opsin 4a (melanopsin), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
opsin 4a (melanopsin), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
opsin 4a (melanopsin), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
opsin 4a (melanopsin), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bone morphogenetic protein receptor, type IAa, transcript variant X1
bone morphogenetic protein receptor, type IAa, transcript variant X2
bone morphogenetic protein receptor, type IAa
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutamate dehydrogenase, mitochondrial, transcript variant X2
glutamate dehydrogenase, mitochondrial, transcript variant X1
glutamate dehydrogenase, mitochondrial isoform X2
glutamate dehydrogenase, mitochondrial isoform X1
shieldin complex subunit 2, transcript variant X1
shieldin complex subunit 2, transcript variant X2
GRIN2-like protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
GRIN2-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
GRIN2-like protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized protein LOC122541767 isoform X1
uncharacterized protein LOC561476 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC561476 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
placenta-specific protein 9-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
placenta-specific protein 9-like, transcript variant X2
placenta-specific protein 9-like isoform X2
placenta-specific protein 9-like isoform X1
L-threonine ammonia-lyase, transcript variant X6
L-threonine ammonia-lyase, transcript variant X3
L-threonine ammonia-lyase, transcript variant X5
L-threonine ammonia-lyase, transcript variant X2
L-threonine ammonia-lyase, transcript variant X1
L-threonine ammonia-lyase, transcript variant X4
L-threonine ammonia-lyase, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
translocase of inner mitochondrial membrane 23 homolog a (yeast)
mitochondrial import inner membrane translocase subunit Tim23
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
CUE domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
CUE domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
CUE domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
CUE domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
CUE domain-containing protein 2 isoform X1
CUE domain-containing protein 2 isoform X2
F-box and leucine-rich repeat protein 15, transcript variant X1
F-box and leucine-rich repeat protein 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
hypoxia inducible factor 1 subunit alpha inhibitor, transcript variant X2
hypoxia inducible factor 1 subunit alpha inhibitor, transcript variant X1
hypoxia-inducible factor 1-alpha inhibitor isoform X2
hypoxia-inducible factor 1-alpha inhibitor isoform X1
NADH:ubiquinone oxidoreductase subunit B8
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 8, mitochondrial
SEC31 homolog B, COPII coat complex component, transcript variant X1
SEC31 homolog B, COPII coat complex component, transcript variant X4
SEC31 homolog B, COPII coat complex component, transcript variant X3
SEC31 homolog B, COPII coat complex component, transcript variant X5
SEC31 homolog B, COPII coat complex component, transcript variant X2
protein transport protein Sec31A isoform X1
protein transport protein Sec31A isoform X3
protein transport protein Sec31A isoform X2
protein transport protein Sec31A isoform X4
wingless-type MMTV integration site family, member 8b
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC122541783, transcript variant X2
uncharacterized LOC122541783, transcript variant X3
uncharacterized LOC122541783, transcript variant X4
uncharacterized LOC122541783, transcript variant X1
transmembrane protein 150A-like, transcript variant X1
transmembrane protein 150A-like, transcript variant X2
transmembrane protein 150A-like isoform X1
transmembrane protein 150A-like isoform X2
uncharacterized protein LOC796266 homolog, transcript variant X1
uncharacterized protein LOC796266 homolog, transcript variant X2
uncharacterized protein LOC796266 homolog, transcript variant X3
uncharacterized protein LOC796266 homolog, transcript variant X4
eukaryotic translation initiation factor 4E binding protein 2, transcript variant X1
eukaryotic translation initiation factor 4E-binding protein 2 isoform X1
eukaryotic translation initiation factor 4E binding protein 2, transcript variant X2
eukaryotic translation initiation factor 4E-binding protein 2 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 14, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 14, transcript variant X1
A disintegrin and metalloproteinase with thrombospondin motifs 14, transcript variant X2
A disintegrin and metalloproteinase with thrombospondin motifs 3 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 14 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 14 isoform X3
steroidogenic acute regulatory protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
microsomal triglyceride transfer protein-like, transcript variant X2
microsomal triglyceride transfer protein-like, transcript variant X1
microsomal triglyceride transfer protein-like isoform X2
microsomal triglyceride transfer protein-like isoform X1
protein TBATA-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein TBATA-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pyroglutamylated RF-amide peptide receptor-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
pyroglutamylated RF-amide peptide receptor-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
pyroglutamylated RF-amide peptide receptor-like
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
AP2-associated protein kinase 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
AP2-associated protein kinase 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
AP2-associated protein kinase 1-like isoform X1
AP2-associated protein kinase 1-like isoform X2
AP2-associated protein kinase 1-like, transcript variant X3
AP2-associated protein kinase 1-like isoform X3
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like, transcript variant X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like, transcript variant X3
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like isoform X1
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like isoform X3
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
NFU1 iron-sulfur cluster scaffold homolog, mitochondrial-like isoform X2
progestin and adipoQ receptor family member 3-like, transcript variant X5
progestin and adipoQ receptor family member 3-like, transcript variant X4
progestin and adipoQ receptor family member 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
progestin and adipoQ receptor family member 3-like, transcript variant X1
progestin and adipoQ receptor family member 3-like, transcript variant X3
progestin and adipoQ receptor family member 3-like isoform X3
progestin and adipoQ receptor family member 3-like isoform X1
progestin and adipoQ receptor family member 3-like isoform X2
BMP-2-inducible protein kinase-like isoform X3
BMP-2-inducible protein kinase-like isoform X2
BMP-2-inducible protein kinase-like isoform X1
AP2-associated protein kinase 1-like, transcript variant X4
AP2-associated protein kinase 1-like isoform X4
glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
anthrax toxin receptor 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
anthrax toxin receptor 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
anthrax toxin receptor 1-like, transcript variant X3
anthrax toxin receptor 1-like isoform X2
anthrax toxin receptor 1-like isoform X1
anthrax toxin receptor 1-like isoform X3
retinol binding protein 3, transcript variant X1
retinol binding protein 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 20, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
protein tyrosine phosphatase non-receptor type 20, transcript variant X2
protein tyrosine phosphatase non-receptor type 20, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 20, transcript variant X3
protein tyrosine phosphatase non-receptor type 20, transcript variant X6
protein tyrosine phosphatase non-receptor type 20, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 20, transcript variant X1
FERM and PDZ domain-containing protein 2 isoform X7
FERM and PDZ domain-containing protein 2 isoform X2
FERM and PDZ domain-containing protein 2 isoform X4
FERM and PDZ domain-containing protein 2 isoform X3
FERM and PDZ domain-containing protein 2 isoform X6
FERM and PDZ domain-containing protein 2 isoform X5
FERM and PDZ domain-containing protein 2 isoform X1
protein tyrosine phosphatase non-receptor type 20, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FERM and PDZ domain-containing protein 2 isoform X8
mitogen-activated protein kinase 8, transcript variant X2
mitogen-activated protein kinase 8, transcript variant X3
mitogen-activated protein kinase 8, transcript variant X1
mitogen-activated protein kinase 8 isoform X2
mitogen-activated protein kinase 8 isoform X1
mitogen-activated protein kinase 8 isoform X3
rho GTPase-activating protein 22-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
rho GTPase-activating protein 22-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rho GTPase-activating protein 22-like, transcript variant X8
rho GTPase-activating protein 22-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho GTPase-activating protein 22-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
rho GTPase-activating protein 22-like, transcript variant X5
rho GTPase-activating protein 22-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
rho GTPase-activating protein 22-like, transcript variant X7
rho GTPase-activating protein 22-like, transcript variant X4
rho GTPase-activating protein 22-like isoform X1
rho GTPase-activating protein 22-like isoform X3
rho GTPase-activating protein 22-like isoform X2
rho GTPase-activating protein 22-like isoform X5
rho GTPase-activating protein 22-like isoform X4
palmitoyltransferase AKR1, transcript variant X1
palmitoyltransferase AKR1, transcript variant X2
WDFY family member 4, transcript variant X2
WDFY family member 4, transcript variant X1
WDFY family member 4, transcript variant X3
WD repeat- and FYVE domain-containing protein 4 isoform X1
WD repeat- and FYVE domain-containing protein 4 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat-containing protein 18
V-set and transmembrane domain containing 4a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
V-set and transmembrane domain-containing protein 4a isoform X1
V-set and transmembrane domain containing 4a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
V-set and transmembrane domain-containing protein 4a isoform X2
cardiac-enriched FHL2-interacting protein, transcript variant X3
cardiac-enriched FHL2-interacting protein, transcript variant X2
cardiac-enriched FHL2-interacting protein, transcript variant X1
cardiac-enriched FHL2-interacting protein
dorsal root ganglia homeobox, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
dorsal root ganglia homeobox, transcript variant X1
bone morphogenetic protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
bone morphogenetic protein 2-like, transcript variant X1
excision repair cross-complementation group 6, transcript variant X2
excision repair cross-complementation group 6, transcript variant X3
excision repair cross-complementation group 6, transcript variant X1
excision repair cross-complementation group 6, transcript variant X4
DNA excision repair protein ERCC-6 isoform X2
DNA excision repair protein ERCC-6 isoform X1
DNA excision repair protein ERCC-6 isoform X3
DNA excision repair protein ERCC-6 isoform X4
chemokine (C-X-C motif) ligand 12a (stromal cell-derived factor 1), transcript variant X1
chemokine (C-X-C motif) ligand 12a (stromal cell-derived factor 1), transcript variant X2
chemokine (C-X-C motif) ligand 12a (stromal cell-derived factor 1) isoform X1
chemokine (C-X-C motif) ligand 12a (stromal cell-derived factor 1) isoform X2
transmembrane protein 72, transcript variant X3
transmembrane protein 72, transcript variant X2
transmembrane protein 72, transcript variant X1
Ras association domain family member 4a, transcript variant X1
Ras association domain family member 4a, transcript variant X5
Ras association domain family member 4a, transcript variant X4
ras association domain-containing protein 4a isoform X1
ras association domain-containing protein 4a isoform X3
Ras association domain family member 4a, transcript variant X2
Ras association domain family member 4a, transcript variant X3
Ras association domain family member 4a, transcript variant X6
ras association domain-containing protein 4a isoform X2
ras association domain-containing protein 4a isoform X4
Ras association domain family member 4a, transcript variant X7
ras association domain-containing protein 4a isoform X5
polyamine oxidase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
polyamine oxidase, transcript variant X1
peroxisomal N(1)-acetyl-spermine/spermidine oxidase isoform X1
peroxisomal N(1)-acetyl-spermine/spermidine oxidase isoform X2
mitochondrial ribosome-associated GTPase 1, transcript variant X1
mitochondrial ribosome-associated GTPase 1, transcript variant X2
mitochondrial ribosome-associated GTPase 1, transcript variant X3
mitochondrial ribosome-associated GTPase 1 isoform X2
mitochondrial ribosome-associated GTPase 1 isoform X1
mitochondrial ribosome-associated GTPase 1 isoform X3
shadow of prion protein, transcript variant X5
shadow of prion protein, transcript variant X7
shadow of prion protein, transcript variant X3
shadow of prion protein, transcript variant X1
shadow of prion protein, transcript variant X4
shadow of prion protein, transcript variant X2
shadow of prion protein, transcript variant X6
shadow of prion protein, transcript variant X8
shadow of prion protein, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
enoyl CoA hydratase, short chain, 1, mitochondrial
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: enoyl-CoA hydratase, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
calcyon neuron-specific vesicular protein
tubulin, gamma complex associated protein 2
ADAM metallopeptidase domain 8a, transcript variant X1
ADAM metallopeptidase domain 8a, transcript variant X2
disintegrin and metalloproteinase domain-containing protein 8a isoform X1
disintegrin and metalloproteinase domain-containing protein 8a isoform X2
sperm flagellar 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
sperm flagellar 1, transcript variant X1
sperm flagellar 1, transcript variant X3
sperm flagellar 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
sperm flagellar 1, transcript variant X5
sperm flagellar 1, transcript variant X4
sperm flagellar 1, transcript variant X7
sperm flagellar 1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC122541843, transcript variant X2
uncharacterized LOC122541843, transcript variant X1
catechol-O-methyltransferase domain containing 1
catechol O-methyltransferase domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 209 Proteins, and 74% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
voltage-dependent anion-selective channel protein 2, transcript variant X1
voltage-dependent anion-selective channel protein 2, transcript variant X2
voltage-dependent anion-selective channel protein 2
sterile alpha motif domain containing 8, transcript variant X1
sterile alpha motif domain containing 8, transcript variant X2
sterile alpha motif domain containing 8, transcript variant X3
sphingomyelin synthase-related protein 1 isoform X1
sphingomyelin synthase-related protein 1 isoform X2
dual specificity protein phosphatase 13-like, transcript variant X1
dual specificity protein phosphatase 13-like, transcript variant X2
dual specificity protein phosphatase 13-like isoform X1
dual specificity protein phosphatase 13-like isoform X2
dual specificity protein phosphatase 13-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dual specificity phosphatase 29-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
dual specificity phosphatase 29-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
dual specificity phosphatase 29-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
K(lysine) acetyltransferase 6B, transcript variant X1
K(lysine) acetyltransferase 6B, transcript variant X3
K(lysine) acetyltransferase 6B, transcript variant X2
adenosine kinase-like, transcript variant X4
adenosine kinase-like, transcript variant X1
adenosine kinase-like, transcript variant X6
adenosine kinase-like, transcript variant X2
adenosine kinase-like, transcript variant X7
adenosine kinase-like, transcript variant X3
adenosine kinase-like, transcript variant X5
AP-3 complex subunit mu-1, transcript variant X5
AP-3 complex subunit mu-1, transcript variant X3
AP-3 complex subunit mu-1, transcript variant X4
AP-3 complex subunit mu-1, transcript variant X2
AP-3 complex subunit mu-1, transcript variant X1
uncharacterized LOC122541856, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC122541856, transcript variant X2
uncharacterized LOC122541856, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
salivary plasminogen activator beta-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
salivary plasminogen activator beta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
salivary plasminogen activator beta-like, transcript variant X1
salivary plasminogen activator beta-like isoform X3
salivary plasminogen activator gamma-like isoform X2
salivary plasminogen activator beta-like isoform X1
component of inhibitor of nuclear factor kappa B kinase complex, transcript variant X1
component of inhibitor of nuclear factor kappa B kinase complex, transcript variant X2
inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X1
component of inhibitor of nuclear factor kappa B kinase complex, transcript variant X3
inhibitor of nuclear factor kappa-B kinase subunit alpha isoform X2
elongation of very long chain fatty acids protein 5-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
zinc finger protein 503, transcript variant X4
zinc finger protein 503, transcript variant X6
zinc finger protein 503, transcript variant X3
zinc finger protein 503, transcript variant X1
zinc finger protein 503, transcript variant X2
zinc finger protein 503, transcript variant X7
zinc finger protein 503, transcript variant X5
leucine rich melanocyte differentiation associated, transcript variant X3
leucine-rich melanocyte differentiation-associated protein isoform X3
leucine rich melanocyte differentiation associated, transcript variant X2
leucine-rich melanocyte differentiation-associated protein isoform X2
leucine rich melanocyte differentiation associated, transcript variant X1
leucine-rich melanocyte differentiation-associated protein isoform X1
leucine rich melanocyte differentiation associated, transcript variant X4
leucine-rich melanocyte differentiation-associated protein isoform X4
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X9
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X1
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X29
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X26
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X28
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X25
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X27
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X20
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X17
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X24
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X18
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X16
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X10
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X7
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X36
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium-activated potassium channel subunit alpha-1a isoform X28
calcium-activated potassium channel subunit alpha-1a isoform X25
calcium-activated potassium channel subunit alpha-1a isoform X4
calcium-activated potassium channel subunit alpha-1a isoform X27
calcium-activated potassium channel subunit alpha-1a isoform X20
calcium-activated potassium channel subunit alpha-1a isoform X12
calcium-activated potassium channel subunit alpha-1a isoform X24
calcium-activated potassium channel subunit alpha-1a isoform X18
calcium-activated potassium channel subunit alpha-1a isoform X10
calcium-activated potassium channel subunit alpha-1a isoform X7
calcium-activated potassium channel subunit alpha-1a isoform X3
calcium-activated potassium channel subunit alpha-1a isoform X2
calcium-activated potassium channel subunit alpha-1a isoform X26
calcium-activated potassium channel subunit alpha-1a isoform X19
calcium-activated potassium channel subunit alpha-1a isoform X16
calcium-activated potassium channel subunit alpha-1a isoform X11
calcium-activated potassium channel subunit alpha-1a isoform X5
calcium-activated potassium channel subunit alpha-1a isoform X23
calcium-activated potassium channel subunit alpha-1a isoform X17
calcium-activated potassium channel subunit alpha-1a isoform X15
calcium-activated potassium channel subunit alpha-1a isoform X9
calcium-activated potassium channel subunit alpha-1a isoform X6
calcium-activated potassium channel subunit alpha-1a isoform X8
calcium-activated potassium channel subunit alpha-1a isoform X1
calcium-activated potassium channel subunit alpha-1a isoform X35
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium-activated potassium channel subunit alpha-1a isoform X14
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X35
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X34
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X23
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X32
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X30
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X33
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X31
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X22
potassium large conductance calcium-activated channel, subfamily M, alpha member 1a, transcript variant X14
calcium-activated potassium channel subunit alpha-1a isoform X34
calcium-activated potassium channel subunit alpha-1a isoform X33
calcium-activated potassium channel subunit alpha-1a isoform X22
calcium-activated potassium channel subunit alpha-1a isoform X31
calcium-activated potassium channel subunit alpha-1a isoform X29
calcium-activated potassium channel subunit alpha-1a isoform X32
calcium-activated potassium channel subunit alpha-1a isoform X30
calcium-activated potassium channel subunit alpha-1a isoform X21
calcium-activated potassium channel subunit alpha-1a isoform X13
discs, large homolog 5a (Drosophila), transcript variant X7
discs, large homolog 5a (Drosophila), transcript variant X5
discs, large homolog 5a (Drosophila), transcript variant X11
discs, large homolog 5a (Drosophila), transcript variant X9
discs, large homolog 5a (Drosophila), transcript variant X4
discs, large homolog 5a (Drosophila), transcript variant X17
discs, large homolog 5a (Drosophila), transcript variant X15
discs, large homolog 5a (Drosophila), transcript variant X3
discs, large homolog 5a (Drosophila), transcript variant X1
discs, large homolog 5a (Drosophila), transcript variant X2
discs, large homolog 5a (Drosophila), transcript variant X18
discs, large homolog 5a (Drosophila), transcript variant X13
discs, large homolog 5a (Drosophila), transcript variant X12
discs, large homolog 5a (Drosophila), transcript variant X16
discs, large homolog 5a (Drosophila), transcript variant X6
discs, large homolog 5a (Drosophila), transcript variant X10
discs, large homolog 5a (Drosophila), transcript variant X8
discs, large homolog 5a (Drosophila), transcript variant X14
uncharacterized LOC122541870, transcript variant X2
uncharacterized LOC122541870, transcript variant X3
uncharacterized LOC122541870, transcript variant X1
elongation of very long chain fatty acids protein 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
elongation of very long chain fatty acids protein 6-like, transcript variant X1
elongation of very long chain fatty acids protein 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
elongation of very long chain fatty acids protein 6-like, transcript variant X4
elongation of very long chain fatty acids protein 6-like isoform X2
elongation of very long chain fatty acids protein 6-like isoform X1
ferroptosis suppressor protein 1-like, transcript variant X2
ferroptosis suppressor protein 1-like, transcript variant X4
ferroptosis suppressor protein 1-like, transcript variant X3
ferroptosis suppressor protein 1-like, transcript variant X5
ferroptosis suppressor protein 1-like, transcript variant X6
ferroptosis suppressor protein 1-like, transcript variant X1
ferroptosis suppressor protein 1-like, transcript variant X7
ferroptosis suppressor protein 1-like isoform X2
ferroptosis suppressor protein 1-like isoform X1
ferroptosis suppressor protein 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cadherin-related family member 1a, transcript variant X3
cadherin-related family member 1a, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cadherin-related family member 1a, transcript variant X2
cadherin-related family member 1 isoform X3
cadherin-related family member 1 isoform X1
cadherin-related family member 1 isoform X2
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2, transcript variant X1
leucine-rich repeat, immunoglobulin-like and transmembrane domains 2, transcript variant X3
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 isoform X2
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 isoform X1
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 2 isoform X3
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
probable vesicular acetylcholine transporter-A
choline O-acetyltransferase a, transcript variant X1
choline O-acetyltransferase a, transcript variant X2
oxoglutarate dehydrogenase L, transcript variant X2
oxoglutarate dehydrogenase L, transcript variant X1
2-oxoglutarate dehydrogenase-like, mitochondrial
poly (ADP-ribose) glycohydrolase a, transcript variant X1
poly (ADP-ribose) glycohydrolase a, transcript variant X2
poly (ADP-ribose) glycohydrolase a, transcript variant X3
poly (ADP-ribose) glycohydrolase a, transcript variant X4
poly(ADP-ribose) glycohydrolase isoform X1
poly(ADP-ribose) glycohydrolase isoform X2
poly(ADP-ribose) glycohydrolase isoform X3
ribosomal protein S24, transcript variant X1
ribosomal protein S24, transcript variant X3
ribosomal protein S24, transcript variant X2
uncharacterized LOC122541711, transcript variant X1
uncharacterized LOC122541711, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
zinc finger MIZ domain-containing protein 1-like, transcript variant X2
zinc finger MIZ domain-containing protein 1-like isoform X2
zinc finger MIZ domain-containing protein 1-like, transcript variant X3
zinc finger MIZ domain-containing protein 1-like isoform X3
zinc finger MIZ domain-containing protein 1-like, transcript variant X1
zinc finger MIZ domain-containing protein 1-like isoform X1
zinc finger MIZ domain-containing protein 1a
peptidyl-prolyl cis-trans isomerase-like
peptidyl-prolyl cis-trans isomerase-like, transcript variant X2
peptidyl-prolyl cis-trans isomerase-like isoform X2
peptidyl-prolyl cis-trans isomerase-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase-like isoform X1
zinc finger CCHC domain-containing protein 24
polymerase (RNA) III (DNA directed) polypeptide A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
polymerase (RNA) III (DNA directed) polypeptide A, transcript variant X1
polymerase (RNA) III (DNA directed) polypeptide A, transcript variant X2
DNA-directed RNA polymerase III subunit RPC1 isoform X1
DNA-directed RNA polymerase III subunit RPC1 isoform X2
DNA-directed RNA polymerase III subunit RPC1 isoform X3
2-hydroxyacylsphingosine 1-beta-galactosyltransferase-like, transcript variant X2
2-hydroxyacylsphingosine 1-beta-galactosyltransferase-like, transcript variant X1
2-hydroxyacylsphingosine 1-beta-galactosyltransferase-like
nucleolar and coiled-body phosphoprotein 1, transcript variant X2
nucleolar and coiled-body phosphoprotein 1, transcript variant X1
nucleolar and coiled-body phosphoprotein 1 isoform X2
nucleolar and coiled-body phosphoprotein 1 isoform X1
nucleolar and coiled-body phosphoprotein 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
nucleolar and coiled-body phosphoprotein 1 isoform X3
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X1
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X5
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X2
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X3
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X6
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X4
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X7
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X8
calcium/calmodulin-dependent protein kinase (CaM kinase) II gamma 2, transcript variant X9
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X1
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X5
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X6
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X2
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X7
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X3
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X8
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X4
calcium/calmodulin-dependent protein kinase type II subunit gamma isoform X9
uncharacterized LOC122541897, transcript variant X1
uncharacterized LOC122541897, transcript variant X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2a
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 2
zinc finger, SWIM-type containing 8, transcript variant X2
zinc finger, SWIM-type containing 8, transcript variant X1
zinc finger SWIM domain-containing protein 8 isoform X2
zinc finger SWIM domain-containing protein 8 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
coiled-coil-helix-coiled-coil-helix domain containing 1
coiled-coil-helix-coiled-coil-helix domain-containing protein 1
fucosyltransferase 11 (alpha (1,3) fucosyltransferase), transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
fucosyltransferase 11 (alpha (1,3) fucosyltransferase), transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
fucosyltransferase 11 (alpha (1,3) fucosyltransferase), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
fucosyltransferase 11 (alpha (1,3) fucosyltransferase), transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
PH and SEC7 domain-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: PH and SEC7 domain-containing protein 1-like
transfer RNA leucine (anticodon UAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ras-GEF domain-containing family member 1A-like, transcript variant X1
ras-GEF domain-containing family member 1A-like isoform X1
ras-GEF domain-containing family member 1A-like, transcript variant X2
ras-GEF domain-containing family member 1A-like, transcript variant X3
ras-GEF domain-containing family member 1A-like isoform X2
ras-GEF domain-containing family member 1A-like, transcript variant X4
ras-GEF domain-containing family member 1A-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X1
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X5
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X3
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X4
chondroitin sulfate N-acetylgalactosaminyltransferase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chondroitin sulfate N-acetylgalactosaminyltransferase 2
ret proto-oncogene receptor tyrosine kinase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
proto-oncogene tyrosine-protein kinase receptor Ret
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
UDP-galactose/UDP-glucose transporter 7, transcript variant X1
UDP-galactose/UDP-glucose transporter 7, transcript variant X2
UDP-galactose/UDP-glucose transporter 7 isoform X1
UDP-galactose/UDP-glucose transporter 7 isoform X2
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X5
nudix (nucleoside diphosphate linked moiety X)-type motif 13, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
nucleoside diphosphate-linked moiety X motif 13 isoform X1
nucleoside diphosphate-linked moiety X motif 13 isoform X2
nucleoside diphosphate-linked moiety X motif 13 isoform X3
prolyl 4-hydroxylase subunit alpha-1-like, transcript variant X1
prolyl 4-hydroxylase subunit alpha-1-like, transcript variant X3
prolyl 4-hydroxylase subunit alpha-1-like, transcript variant X2
prolyl 4-hydroxylase subunit alpha-1-like, transcript variant X4
prolyl 4-hydroxylase subunit alpha-1-like isoform X1
prolyl 4-hydroxylase subunit alpha-1-like isoform X3
prolyl 4-hydroxylase subunit alpha-1-like isoform X2
prolyl 4-hydroxylase subunit alpha-1-like isoform X4
prolyl 4-hydroxylase subunit alpha-1-like, transcript variant X5
prolyl 4-hydroxylase subunit alpha-1-like isoform X5
phospholipase A2, group XIIB, transcript variant X2
phospholipase A2, group XIIB, transcript variant X1
group XIIB secretory phospholipase A2-like protein isoform X1
group XIIB secretory phospholipase A2-like protein isoform X2
oncoprotein-induced transcript 3 protein
mitochondrial calcium uniporter, transcript variant X3
mitochondrial calcium uniporter, transcript variant X1
mitochondrial calcium uniporter, transcript variant X2
calcium uniporter protein, mitochondrial isoform X3
calcium uniporter protein, mitochondrial isoform X1
calcium uniporter protein, mitochondrial isoform X2
mitochondrial calcium uptake 1, transcript variant X1
mitochondrial calcium uptake 1, transcript variant X2
mitochondrial calcium uptake 1, transcript variant X4
mitochondrial calcium uptake 1, transcript variant X5
mitochondrial calcium uptake 1, transcript variant X3
mitochondrial calcium uptake 1, transcript variant X6
calcium uptake protein 1, mitochondrial isoform X1
calcium uptake protein 1, mitochondrial isoform X2
calcium uptake protein 1, mitochondrial isoform X4
calcium uptake protein 1, mitochondrial isoform X5
calcium uptake protein 1, mitochondrial isoform X3
calcium uptake protein 1, mitochondrial isoform X6
DnaJ heat shock protein family (Hsp40) member B12a, transcript variant X1
DnaJ heat shock protein family (Hsp40) member B12a, transcript variant X2
dnaJ homolog subfamily B member 12a isoform X1
dnaJ homolog subfamily B member 12a isoform X2
activating signal cointegrator 1 complex subunit 1, transcript variant X2
activating signal cointegrator 1 complex subunit 1, transcript variant X1
activating signal cointegrator 1 complex subunit 1
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2, transcript variant X1
SPARC (osteonectin), cwcv and kazal like domains proteoglycan 2, transcript variant X2
DNA damage-inducible transcript 4 protein
trypsin like peroxisomal matrix peptidase 1, transcript variant X2
trypsin like peroxisomal matrix peptidase 1, transcript variant X1
peroxisomal leader peptide-processing protease isoform X2
peroxisomal leader peptide-processing protease isoform X1
protein transport protein Sec24A-like, transcript variant X1
protein transport protein Sec24A-like, transcript variant X5
protein transport protein Sec24A-like, transcript variant X4
protein transport protein Sec24A-like, transcript variant X3
protein transport protein Sec24A-like, transcript variant X2
protein transport protein Sec24A-like isoform X3
protein transport protein Sec24A-like isoform X1
protein transport protein Sec24A-like isoform X4
protein transport protein Sec24A-like isoform X2
calcium-binding mitochondrial carrier protein SCaMC-1-A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments
biogenesis of lysosomal organelles complex-1, subunit 2
biogenesis of lysosome-related organelles complex 1 subunit 2
heterogeneous nuclear ribonucleoprotein D0-like
cadherin-related 23, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
cadherin-related 23, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
V-type immunoglobulin domain-containing suppressor of T-cell activation
uncharacterized protein C10orf105-like, transcript variant X1
uncharacterized protein C10orf105-like, transcript variant X3
uncharacterized protein C10orf105-like, transcript variant X2
cadherin-related 23, transcript variant X2
cadherin-related 23, transcript variant X3
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
unc-5 netrin receptor B, transcript variant X1
unc-5 netrin receptor B, transcript variant X7
unc-5 netrin receptor B, transcript variant X4
unc-5 netrin receptor B, transcript variant X3
unc-5 netrin receptor B, transcript variant X2
unc-5 netrin receptor B, transcript variant X5
unc-5 netrin receptor B, transcript variant X6
uncharacterized LOC122541929, transcript variant X2
uncharacterized LOC122541929, transcript variant X4
uncharacterized LOC122541929, transcript variant X1
uncharacterized LOC122541929, transcript variant X6
uncharacterized LOC122541929, transcript variant X7
uncharacterized LOC122541929, transcript variant X3
uncharacterized LOC122541929, transcript variant X5
uncharacterized LOC122541929, transcript variant X8
pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha
pterin-4-alpha-carbinolamine dehydratase
sphingosine-1-phosphate lyase 1, transcript variant X1
sphingosine-1-phosphate lyase 1, transcript variant X2
sphingosine-1-phosphate lyase 1 isoform X1
sphingosine-1-phosphate lyase 1 isoform X2
paired-like homeodomain 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
paired-like homeodomain 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
paired-like homeodomain 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
paired-like homeodomain 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X1
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X3
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X6
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X2
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X4
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X7
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X5
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X8
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X11
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X1
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X3
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X6
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X2
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X4
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X7
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X5
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X8
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X11
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X9
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X12
golgi brefeldin A resistant guanine nucleotide exchange factor 1, transcript variant X10
Golgi-specific brefeldin A-resistance guanine nucleotide exchange factor 1 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
core histone macro-H2A.2, transcript variant X3
core histone macro-H2A.2, transcript variant X1
core histone macro-H2A.2, transcript variant X2
collagen, type XIII, alpha 1, transcript variant X2
collagen, type XIII, alpha 1, transcript variant X1
collagen, type XIII, alpha 1, transcript variant X3
collagen, type XIII, alpha 1, transcript variant X8
collagen, type XIII, alpha 1, transcript variant X12
collagen, type XIII, alpha 1, transcript variant X16
collagen, type XIII, alpha 1, transcript variant X13
collagen, type XIII, alpha 1, transcript variant X6
collagen, type XIII, alpha 1, transcript variant X5
collagen, type XIII, alpha 1, transcript variant X10
collagen, type XIII, alpha 1, transcript variant X11
collagen, type XIII, alpha 1, transcript variant X9
collagen, type XIII, alpha 1, transcript variant X15
collagen, type XIII, alpha 1, transcript variant X14
collagen, type XIII, alpha 1, transcript variant X18
collagen, type XIII, alpha 1, transcript variant X19
collagen, type XIII, alpha 1, transcript variant X20
collagen, type XIII, alpha 1, transcript variant X4
collagen, type XIII, alpha 1, transcript variant X22
collagen, type XIII, alpha 1, transcript variant X21
collagen, type XIII, alpha 1, transcript variant X23
collagen, type XIII, alpha 1, transcript variant X17
collagen, type XIII, alpha 1, transcript variant X7
collagen, type XIII, alpha 1, transcript variant X24
collagen, type XIII, alpha 1, transcript variant X25
collagen alpha-1(XIII) chain isoform X15
collagen alpha-1(XIII) chain isoform X14
collagen alpha-1(XIII) chain isoform X18
collagen alpha-1(XIII) chain isoform X19
collagen alpha-1(XIII) chain isoform X20
collagen alpha-1(XIII) chain isoform X24
collagen alpha-1(XIII) chain isoform X22
collagen alpha-1(XIII) chain isoform X25
collagen alpha-1(XIII) chain isoform X13
collagen alpha-1(XIII) chain isoform X21
collagen alpha-1(XIII) chain isoform X23
collagen alpha-1(XIII) chain isoform X17
cGMP-dependent protein kinase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cGMP-dependent protein kinase 2, transcript variant X3
cGMP-dependent protein kinase 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
cGMP-dependent protein kinase 2 isoform X1
cGMP-dependent protein kinase 2 isoform X3
cGMP-dependent protein kinase 2 isoform X2
cGMP-dependent protein kinase 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cGMP-dependent protein kinase 2 isoform X4
protein FAM241B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein FAM241B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein FAM241B-like, transcript variant X3
broad substrate specificity ATP-binding cassette transporter ABCG2-like
ubiquitin specific peptidase 54a, transcript variant X1
ubiquitin specific peptidase 54a, transcript variant X2
ubiquitin specific peptidase 54a, transcript variant X3
inactive ubiquitin carboxyl-terminal hydrolase 54a isoform X1
ubiquitin specific peptidase 54a, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inactive ubiquitin carboxyl-terminal hydrolase 54a isoform X2
synaptopodin 2-like protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
synaptopodin 2-like protein, transcript variant X2
protein transport protein Sec24C-like, transcript variant X1
protein transport protein Sec24C-like, transcript variant X2
protein transport protein Sec24C-like isoform X1
protein transport protein Sec24C-like isoform X2
coiled-coil serine-rich protein 2a, transcript variant X3
coiled-coil serine-rich protein 2a, transcript variant X4
coiled-coil serine-rich protein 2a, transcript variant X1
coiled-coil serine-rich protein 2a, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
coiled-coil serine-rich protein 2a, transcript variant X5
coiled-coil serine-rich protein 2a, transcript variant X6
serine-rich coiled-coil domain-containing protein 2 isoform X3
serine-rich coiled-coil domain-containing protein 2 isoform X2
serine-rich coiled-coil domain-containing protein 2 isoform X1
serine-rich coiled-coil domain-containing protein 2 isoform X4
serine-rich coiled-coil domain-containing protein 2 isoform X5
glutamate receptor ionotropic, delta-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
wings apart-like protein homolog, transcript variant X2
wings apart-like protein homolog, transcript variant X1
wings apart-like protein homolog, transcript variant X4
wings apart-like protein homolog, transcript variant X3
wings apart-like protein homolog isoform X2
wings apart-like protein homolog isoform X1
pro-neuregulin-3, membrane-bound isoform-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns